Patients with bladder cancer present urothelial cell cycle dysregulation including aberrant activity of CDK4 [43,44], while overexpression of HGF is known to be involved in early stages of carcinogenesis [63]. The gene discussed is HGF; the disease is urinary bladder cancer.